Digital Biotech Innovation

Course Objectives

Why are digital tech giants such as Alphabet, Amazon, Microsoft and even Japan’s Softbank investing heavily in healthcare and biotech? In the Technovate era, we are currently witnessing a shift towards new kinds of collaboration between digitech and biotech. The World Economic Forum coined biotech as one of the key enablers of the Fourth Industrial Revolution alongside AI, IoT and 5G network.

Whether you are working in the biotech industry looking for ways to incorporate digital technologies, or working in the digital industry looking for business applications in biotech, the business opportunities are vast. However, key fundamental differences in these two industries still present great challenges for business leaders.

This course aims to provide students with a solid understanding of the biotech industry. We will identify new opportunities and examine the challenges. We will also discuss how to strategically drive biotech innovation in both startups and established companies.

Although, we will focus mainly on healthcare and pharmatech in this course, we will also discuss examples from  subcategories such as food, agriculture and energy.

This course is intended for all students who are interested in learning more about the biotech industry, regardless of their experience.

Course Details

Programs: Full-time MBA, Part-time MBA
Discipline: Special Course
Course Level: Specialized Course
Special Features: None
Required/Elective Course: Elective Course
Number of Credits: 1.0
Report: Day 4
Hours Per Class: 3 hours
Class Capacity: 25

*Due to the characteristics of the course, application of the substitute class and leave of absence system is not available.

 

Theme/Reading Materials

Day 1
Session A
THEME Introduction to the BioTech and Healthcare Industries
CASE Case: Neurotrack and the Alzheimer’s Puzzle
Session B
THEME Introduction to the BioTech and Healthcare Industries
CASE Case: Neurotrack and the Alzheimer’s Puzzle
 
Day 2
Session A
THEME Innovation in BioTech Startups
CASE Resilience at Intermune: A Journey Through the Valley of the Shadow of Death
Session B
THEME Innovation in BioTech Startups
CASE Resilience at Intermune: A Journey Through the Valley of the Shadow of Death
 
Day 3
Session A
THEME Innovation in Established BioTech Companies
CASE Amgen: Pursuing Innovation and Imitation?
Session B
THEME Innovation in Established BioTech Companies
CASE Amgen: Pursuing Innovation and Imitation?
 
Day 4
Session A
THEME Presentation and Macro-environment (Government, Politics and Laws) in Biotech Management
CASE Healthcare.gov: The Crash and the Fix
Session B
THEME Presentation and Macro-environment (Government, Politics and Laws) in Biotech Management
CASE Healthcare.gov: The Crash and the Fix

Faculty

David Yeregui Marcos del Blanco
David Yeregui Marcos del Blanco
Marketing and Strategy
Dr. David Yeregui Marcos del Blanco is a Process and Robotics Engineer (2005) and PhD in Production and Computing Engineering with honors from the University of Leon (2018). He also holds an M.Sc. Degree in International Business Management from the ICEX (Ministry of Industry, Tourism and Commerce of Spain). David has co-authored over 10 articles in high-impact journals in the Cybersecurity and Biotech fields.